Suchergebnisse - "*Ritonavir"

PubPharm (1.450)

1

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

enthalten in: Clinical pharmacokinetics | 2024

von Rohr, B. | Krohmer, E. | Foerster, K. | +5

2

Proof-of-concept studies with a computationally designed Mpro inhibitor as a synergistic combination regimen alternative to Paxlovid

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Papini, C. | Ullah, I. | Ranjan, A. | +11

3

Real-world application of nirmatrelvir/ritonavir in hospitalized COVID-19 patients with onset of symptoms beyond 5 days : a comparative study

enthalten in: Infection | 2024

von Luo, W. | Li, K. | Dai, C. | +7

4

A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication

enthalten in: Antiviral research | 2024

von Moon, C. | Porges, E. | Roberts, A. | +1

5

Physiologically-based pharmacokinetic modelling guided dose evaluations of nirmatrelvir/ritonavir in renal impairment for the management of COVID-19

enthalten in: British journal of clinical pharmacology | 2024

von Ng, T. | Wang, Z. | Chan, E.

6

Ritonavir : 25 Years' Experience of Concomitant Medication Management. A Narrative Review

enthalten in: Infectious diseases and therapy | 2024

von Quercia, R. | Di Perri, G. | Pein, C. | +4

7

Review : The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Meyerowitz, E. | Li, Y.

8

Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19

enthalten in: BMJ open respiratory research | 2024

von Zhang, H. | Xiaojiao, T. | Chen, J. | +8

9

The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants

enthalten in: Expert review of anti-infective therapy | 2024

von Hsu, C. | Hsu, W. | Shiau, B. | +6

10

Mild SARS-CoV-2 infection in vulnerable patients : implementation of a clinical pathway for early treatment

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2024

von Pinargote-Celorio, H. | Otero-Rodríguez, S. | González-de-la-Aleja, P. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[145]